Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy
- 15 February 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 85 (4), 491-493
- https://doi.org/10.1016/s0002-9149(99)00778-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Meeting HighlightsCirculation, 1999
- Differences between Activation Thresholds for Platelet P-Selectin and Glycoprotein IIb-IIIa Expression and Their Clinical ImplicationsThrombosis Research, 1999
- Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjectsThe American Journal of Cardiology, 1999
- The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidineThe American Journal of Cardiology, 1999
- Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trialJournal of the American College of Cardiology, 1999
- Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein:: a potential contributor to cardiovascular riskJournal of the American College of Cardiology, 1999
- Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) InhibitorsBlood, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994